老化におけるヨウ素と甲状腺機能障害:高齢者の栄養学,薬学,微生物修飾剤
Corina-Aurelia Zugravu1,2, Marta Petre2, Ciprian Constantin3,4
1Department of Hygiene and Nutrition, "Carol Davila" University of Medicine and Pharmacy, 050463 Bucharest, Romania.
Geriatrics (Basel, Switzerland)
|February 20, 2026
まとめ
老化は,食事,薬,腸の健康に影響されるヨウ素代謝の変化を通じて甲状腺機能に影響します. ヨウ素の摂取量をモニタリングし,年齢特有の甲状腺の範囲を使用することは,高齢者のための鍵です.
科学分野:
- エンドクリノロジー エンドクリノロジー
- ゲロントロジーはゲロントロジーの学科です.
- 栄養科学とは,栄養科学である.
背景:
- 老化により,内分泌の調節と栄養素の代謝が変化し,年配の成人では甲状腺機能障害のリスクが高まります.
- ヨウ素の狭い生理学的範囲は,栄養,薬,腎機能,腸内微生物群との相互作用により,老化する個人を脆弱にします.
研究 の 目的:
- 老化がヨウ素-甲状腺ホメオスタシスにどのように影響するかを検討します.
- ダイエット,薬,腸内微生物群,およびヨウ素の取り扱いと甲状腺ホルモンの経済における代謝変化の役割を強調する.
主な方法:
- 既存の証拠のナラティブレビュー.
- 生理学的老化,栄養素代謝,甲状腺機能に関するデータの統合.
主要な成果:
- 生理学的老化は,腎臓のヨウ素クリアランス,甲状腺のリザーブ,ホルモン変換を低下させる.
- 多剤療法と慢性炎症は,ヨウ素不均衡と甲状腺機能障害に対する感受性を高めます.
- 年齢に関連した腸内不活性症は,腸内生態と甲状腺の自己免疫を結びつけ,栄養素の吸収に影響を与える可能性があります.
結論:
- ヨウ素摂取量の変動は,高齢化における甲状腺機能障害の重要な決定因子である.
- 栄養学,薬学,その他の要因は,ヨウ素に関連した甲状腺の脆弱性を変化させます.
- 年齢に応じて調整された甲状腺の範囲とモニタリングは,過剰な治療を予防し,代謝回復力を高めることができます.
関連する概念動画
Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274


